89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE

Clinical trial NCT03556046 · COMPLETED

Trial details

NCT number: NCT03556046
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Carcinoma

Start date: 2018-04-05
Primary completion: 2018-12-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.